We are live on ! Find out more
TTPH

Tetraphase Pharmaceuticals, Inc.
TTPH

Delisted

TTPH was delisted on the 28th of July, 2020.

Back to rankings

73 hedge funds and large institutions have $285M invested in Tetraphase Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

54% more capital invested

Capital invested by funds: $185M → $285M (+$99.9M)

29% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 17

14% more funds holding

Funds holding: 64 → 73 (+9)

6% less call options, than puts

Call options by funds: $2.16M | Put options by funds: $2.29M

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
73
Holders Change
+9
Holders Change %
+14.06%
% of All Funds
2.12%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
18
Increased
22
Reduced
17
Closed
9
Calls
$2.16M
Puts
$2.29M
Net Calls
-$134K
Net Calls Change
-$447K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$6.76M
2
Fidelity International
Fidelity International
Bermuda
+$5.96M
3
CPIM
Columbia Partners Investment Management
Virginia
+$5.11M
4
GIM
Granahan Investment Management
Massachusetts
+$4.13M
5
Nomura Holdings
Nomura Holdings
Japan
+$3.39M

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$15.5M
2
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
-$10.9M
3
PC
PointState Capital
New York
-$5.36M
4
SFM
Sphera Funds Management
Israel
-$2.62M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
TC
26
TFS Capital
Pennsylvania
$2.65M +$765K +2,856 +75%
RFC
27
Russell Frank Company
Washington
$2.19M +$1.47M +5,495 New
CWG
28
C WorldWide Group
Denmark
$2M +$1.34M +5,000 New
USAA
29
United Services Automobile Association
Texas
$1.92M +$683K +2,550 +113%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$1.79M +$38.3K +143 +3%
Axa
31
Axa
France
$1.6M +$1.07M +4,004 New
TCIM
32
TIAA CREF Investment Management
New York
$1.59M -$52.8K -197 -5%
Invesco
33
Invesco
Georgia
$1.56M +$1.05M +3,915 New
GF
34
Gabelli Funds
New York
$1.54M +$495K +1,850 +93%
Deutsche Bank
35
Deutsche Bank
Germany
$1.48M -$150K -561 -13%
Ameriprise
36
Ameriprise
Minnesota
$1.39M +$932K +3,479 +173,950%
BIM
37
BlackRock Investment Management
Delaware
$1.28M +$9.11K +34 +1%
GACM
38
Green Arrow Capital Management
New York
$1.2M – – –
BCM
39
Bridgeway Capital Management
Texas
$998K – – –
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$812K +$5.62K +21 +1%
GPCM
41
Granite Point Capital Management
Massachusetts
$798K +$536K +2,000 New
SIA
42
Sit Investment Associates
Minnesota
$705K +$473K +1,767 New
Charles Schwab
43
Charles Schwab
California
$645K – – –
TA
44
Teachers Advisors
New York
$615K – – –
DCM
45
Dupont Capital Management
Delaware
$539K +$94.8K +354 +36%
Bank of America
46
Bank of America
North Carolina
$452K -$5.62K -21 -2%
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$441K +$47.7K +178 +19%
MLICM
48
Metropolitan Life Insurance Company (MetLife)
New York
$357K – – –
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$342K – – –
VOYA Investment Management
50
VOYA Investment Management
Georgia
$337K – – –
1
2
3 4

TTPH Hedge Fund Activity: Q3 2014 in Review

73 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q3 2014, worth a combined $285M — up 54% from $185M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new TTPH positions and 9 closed out — a net gain of 9 holders — while 22 added to existing stakes and 17 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $6.76M. The largest seller was Broadfin Capital, cutting an estimated $15.5M.

  • 73 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q3 2014, up from 64 in Q2 2014.
  • Funds reported $285M of Tetraphase Pharmaceuticals, Inc. stock for Q3 2014, up 54% quarter-over-quarter.
  • 18 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q3 2014 and 9 closed out, a net change of +9 holders.
  • The largest Tetraphase Pharmaceuticals, Inc. buyer in Q3 2014 was Adage Capital Partners, an estimated $6.76M added.
  • The largest Tetraphase Pharmaceuticals, Inc. seller in Q3 2014 was Broadfin Capital, an estimated $15.5M sold.

Based on aggregated 13F filings for Q3 2014.